Skip to main content
Figure 3 | Molecular Medicine

Figure 3

From: Potential of the Trifunctional Bispecific Antibody Surek Depends on Dendritic Cells: Rationale for a New Approach of Tumor Immunotherapy

Figure 3

Surek induces killing of B78-D14 cells in vitro in cultures containing T cells and DCs. All groups contained 1 × 105 B78-D14 or B16-EpCAM cells per well at the beginning of the experiment on d 0. (A) FACS analysis of cocultures on d 4. Dead cells were excluded by PI staining. Viable tumor cells were detected by gating for PI-negative, CD8, CD4, CD11c, CD11b and GD2+ cells. Numbers of living tumor cells per well were enumerated by using counting beads. (B) Microscopic pictures of cocultures. Almost no living (adherent) B78-D14 tumor cells are detectable in cocultures containing DCs, T cells and Surek on d 6 in contrast to the control groups containing DCs and T cells without Surek or T cells alone with Surek. Magnification 20×. (C) Tumor cell killing assessed in XTT assays. Only intact Surek antibody in combination with DCs induced tumor cell elimination. Corresponding bsF(ab′)2 fragments were ineffective even in the presence of DCs.

Back to article page